# Task B6: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, Including SARS-CoV-2

> **NIH NIH N01** · UTAH STATE UNIVERSITY · 2021 · $272,532

## Abstract

This contract provides in vitro testing of potential anti-viral agents, maintenance of viral stocks and cell lines needed to grow the viruses, and development of related assays.

## Key facts

- **NIH application ID:** 10409271
- **Project number:** 75N93019D00021-0-759302100001-2
- **Recipient organization:** UTAH STATE UNIVERSITY
- **Principal Investigator:** BRETT HURST
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $272,532
- **Award type:** —
- **Project period:** 2021-05-03 → 2022-05-02

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10409271

## Citation

> US National Institutes of Health, RePORTER application 10409271, Task B6: In Vitro Assessment for Antimicrobial Activity Against Respiratory Viruses, Including SARS-CoV-2 (75N93019D00021-0-759302100001-2). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10409271. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*